Infectious Agent May Drive Alzheimer Disease Pathology
New research has suggested that Alzheimer disease pathology may be driven by an infectious agent, Porphyromonas gingivalis.
Congress Votes to Pass the Right-to-Try Bill
Congress has voted to pass the right-to-try bill, which will provide terminally ill patients with the ability to seek out experimental therapies not yet approved by the FDA.
IMI/REL Proves Effective Against Certain Drug-Resistant Bacterial Infections
Investigational beta-lacatamase inhibitor IMI/REL demonstrates a favorable overall response against certain imipenem-non-susceptible bacterial infections.
Timing of ART & Consistency of Utilization Is Paramount in Perinatal HIV Patients
At CROI 2018, Dr. Patricia Flynn discussed the impact of ART on individuals with perinatal HIV infections, and how far the infectious disease community has come since its initial use.
Early Days of HIV/AIDS Spurred Many Advancements in the Medical Community
The medical community has learned many lessons by looking back on the early days of the HIV/AIDS epidemic, including the value of multidisciplinary teams, the vital role of acute care clinicians, and more.
CDC Director Brenda Fitzgerald Resigns
Amid alleged tobacco investments, Brenda Fitzgerald has resigned from her position as director of the CDC.
Alex Azar Confirmed as New HHS Secretary: Is He the Right Man for the Job?
Can a prior pharmaceutical company president successfully address ever-climbing medication costs in the United States?
Stanford Investigators Are Building a Better HIV Test
The test combines the convenience of the saliva test with the reliability of the blood test.
FDA Warns of Adverse Event Associated with Compounded Drugs Containing Vancomycin
The FDA recently issued a Compounding Risk Alert related to a rare, adverse event associated with compounded triamcinolone, moxifloxacin, and vancomycin: potential blindness.
2 Clarke Drive Cranbury, NJ 08512